CanaQuest Medical Corp.: CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.TORONTO, ON / ACCESSWIRE / December 8
Source: finanznachrichten.de